Pfizer said its experimental Lyme disease vaccine was more than 70% efficacious in reducing confirmed cases of the tickborne ...
The vaccine could represent a weapon for preventing Lyme, a bacterial infection carried by ticks that is diagnosed and ...
Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above -- The investigational vaccine candidate was well tolerated ...
Augments Pfizer’s efforts to advance investigational medicines for cardiometabolic diseases Pfizer plans to conduct combination studies of YP05002 with its glucose-dependent insulinotropic polypeptide ...
Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC ("Tutanota") to purchase up to 1 million shares of Pfizer common stock at a ...
Hosted on MSN
Pfizer shares drop on quarterly loss
Pfizer reported a quarterly loss Tuesday following a large write-down, denting shares as it confirmed 2026 financial targets with lower revenues. The big US drugmaker pointed to another drop in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results